Brenda Chyla, PhD

Principal Research Scientist
AbbVie Inc.
North Chicago, IL, United States

N/A

Presentation(s):

• (1553189) Recurrent Genomic Alterations in the Apoptotic Machinery in Patients With CLL Treated With Venetoclax Monotherapy Following Treatment With BCRi

  Sunday, October 8, 2023
  12:25 PM – 12:35 PM EDT

• (1550119) Final 7-year Follow Up and Retreatment Substudy Analysis of MURANO: Venetoclax-Rituximab-Treated Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

  Sunday, October 8, 2023
  3:05 PM – 3:10 PM EDT